Author name: Ambi Singh

The Rise of GLP-1 & Dual-Agonist Weight-Loss Drugs in the UK The Rise of GLP-1 & Dual-Agonist Weight-Loss Drugs in the UK Introduction GLP-1 receptor agonists and dual-agonist weight-loss medications, such as Semaglutide and Tirzepatide, have rapidly reshaped the weight-management landscape in the UK. These medications are now among the most searched, prescribed, and talked-about […]

Pharmazon HomeCare named finalist in the 2025 Allica Bank Great British Entrepreneur Awards` London, UK – Pharmazon HomeCare has been named a finalist in the 2025 Allica Bank Great British Entrepreneur Awards, shortlisted in the Innovation Entrepreneur of the Year category.  Known as “The Grammys of Entrepreneurship”, the awards celebrate the most exceptional and inspiring

Simplifying ADHD Treatment Access: Digital Pharmacy Support for Patients & Clinicians When Focus Feels Just Out of Reach It often starts with a small frustration — missed deadlines, forgotten tasks, conversations that drift away mid-sentence. For parents, it can look like constant reminders and endless energy; for adults, it can feel like trying to live

The New Era of Weight Loss: Medications Changing the UK Why Obesity Care Needs More Than Diet Advice For decades, weight loss advice has sounded the same: eat less, move more. But if it were really that simple, we wouldn’t be facing today’s reality. Obesity is now recognised as a chronic disease, driven not just

When it comes to treating erectile dysfunction (ED), two of the most well-known medications are Tadalafil and Sildenafil. While they share similarities, there are key differences that may influence which one is best for you or your patients.  How They Work  Both Tadalafil and Sildenafil belong to a group of drugs called PDE5 inhibitors. They

With obesity rates rising globally, medical advancements in weight loss treatments have become a hot topic. One of the latest developments is CagriSema, a combination of Cagrilintide and Semaglutide, designed to aid significant weight loss. But how does it work, and when can patients expect it to hit the market?  What is CagriSema?  CagriSema is

Mounjaro for Weight Management and Type 2 Diabetes Mounjaro (tirzepatide) is indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. It is also approved for the treatment of adults with type 2 diabetes mellitus to improve glycemic control, alongside diet and exercise. Mounjaro

Saxenda for Weight Management Saxenda (liraglutide) is indicated for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. It should be used in conjunction with a reduced-calorie diet and increased physical activity. Saxenda mimics the hormone GLP-1, which helps regulate appetite and caloric intake, promoting

Ozempic for Weight Management Ozempic (semaglutide) is a once-weekly injection designed to assist in managing blood sugar levels in adults with type 2 diabetes mellitus. It works by mimicking the action of glucagon-like peptide-1 (GLP-1), a hormone that plays a crucial role in glucose metabolism. Beyond its primary indication, Ozempic is also prescribed off-label for